Neonatal hTSH FEIA Plus

Accurate neonatal thyroid screening for early detection of congenital hypothyroidism.

Overview

Overview

The Labsystems Diagnostics Neonatal hTSH FEIA Plus is a fluorometric enzyme immunoassay designed for the quantitative determination of human thyroid-stimulating hormone (hTSH) in dried blood spot samples. It serves as a primary screening test for congenital hypothyroidism (CH) in newborns, enabling early diagnosis and timely intervention to prevent developmental complications. The assay elutes hTSH from dried blood disks and forms a specific sandwich complex between two antibodies—one immobilized on the solid phase and another labeled with horseradish peroxidase (HRP). The resulting fluorescence signal is directly proportional to the hTSH concentration, ensuring reliable and reproducible results.

Features

Features

  • High analytical sensitivity for precise detection of low hTSH levels
  • Reliable quantitation from dried blood spot samples
  • Fluorometric enzyme immunoassay for consistent and stable performance
  • Compatible with Labsystems Diagnostics’ neonatal screening platforms
  • Optimized assay design for easy workflow integration in newborn screening laboratories

Technical Specifications

  • Format : 10 solid plates / 960 wells
  • Catalogue Number : 6199880

Performance & Applications

Performance

  • Minimal background ensuring clean and accurate readings
  • Excellent stability across assay runs and conditions
  • Strong correlation with CDC reference samples
  • Calibrated against international standards (WHO and ISNS) for globally comparable results

Applications

  • Primary neonatal screening for congenital hypothyroidism (CH)
  • Routine use in public health laboratories and hospital-based screening centers

Need Guidance?
Our Experts Are Here for You.

Neonatal hTSH FEIA Plus | Trivitron Health Care